Results
90
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
90 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.49 | 2.3% | 14.6% | SEK 404.0m | SEK 2.20 | PS3.5x | E86.1% | n/a | Tech | ||
CALTX | SEK 206.60 | 0% | 113.7% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 301.00 | 27.3% | 199.2% | SEK 25.9b | SEK 267.50 | PE133.7x | E44.3% | n/a | Software | ||
CTT | SEK 284.00 | 1.1% | 33.3% | SEK 3.6b | n/a | PE34.9x | E24.8% | 1.9% | Capital Goods | ||
YIELD | SEK 2.15 | -2.3% | -67.0% | SEK 123.2m | SEK 9.00 | PB1.4x | E111.5% | n/a | Diversified Financials | ||
MAGLE | SEK 40.40 | 3.1% | 29.5% | SEK 436.3m | SEK 50.00 | PE56.7x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
BIOA B | SEK 153.00 | -0.4% | -49.7% | SEK 13.5b | SEK 320.40 | PS53.6x | E102.8% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 1.60 | -0.1% | 31.0% | SEK 64.8m | n/a | PS2x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.85 | 0% | -66.1% | SEK 239.6m | SEK 7.90 | PS32.8x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.22 | -0.4% | -21.6% | SEK 240.1m | SEK 3.65 | PS2.2x | E115.6% | n/a | Tech | ||
ORGC | SEK 3.15 | -3.7% | -28.2% | SEK 309.1m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
CRAD B | SEK 43.80 | -0.3% | 41.5% | SEK 1.5b | SEK 57.00 | PE27.5x | E33.9% | n/a | Healthcare | ||
FLEXQ | SEK 11.95 | 12.7% | -38.1% | SEK 160.2m | SEK 25.00 | PS1.4x | E118.7% | n/a | Capital Goods | ||
CTM | SEK 6.58 | 2.3% | -67.7% | SEK 497.8m | SEK 29.70 | PB0.3x | E123.4% | 0% | Media | ||
ESGR B | SEK 29.80 | -2.3% | -56.2% | SEK 196.3m | SEK 58.00 | PS1.1x | E57.0% | n/a | Household | ||
MIDS | SEK 1.25 | -0.5% | -38.0% | SEK 261.3m | SEK 2.80 | PS4.1x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 7.05 | 1.4% | -24.2% | SEK 208.0m | SEK 16.50 | PS4x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.51 | 50.3% | -1.2% | SEK 66.7m | SEK 1.00 | PB2.3x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 35.06 | 5.2% | 1.3% | SEK 12.1b | SEK 54.83 | PE25.3x | E21.5% | 1.1% | Software | ||
4C | SEK 19.10 | -6.8% | -14.7% | SEK 671.0m | SEK 22.00 | PS2.3x | E108.0% | n/a | Software | ||
EQT | SEK 331.10 | 4.6% | 48.9% | SEK 391.4b | SEK 361.36 | PE112.9x | E56.8% | 1.1% | Diversified Financials | ||
FNOX | SEK 54.56 | -14.5% | -7.4% | SEK 33.3b | SEK 73.00 | PE51.2x | E22.3% | 0.4% | Software | ||
EGTX | SEK 5.29 | -9.3% | 27.8% | SEK 1.5b | SEK 13.30 | PS24.6x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
NIUTEC | SEK 6.48 | 5.5% | -40.8% | SEK 132.0m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods |